ISIN | CH1238288059 |
---|---|
Valor Number | 123828805 |
Bloomberg Global ID | |
Fund Name | SYNCHRONY MARKET FUNDS - Synchrony Swiss Equity C |
Fund Provider |
Banque Cantonale de Genève
Genève, Switzerland Phone: +41 58 211 21 11 E-Mail: info@bcge.ch Web: www.bcge.ch |
Fund Provider | Banque Cantonale de Genève |
Representative in Switzerland | |
Distributor(s) |
Banque Cantonale Vaudoise Lausanne Phone: +41 21 212 10 00 |
Asset Class | Equities |
EFC Category | |
Distribution Policy | Distribution |
Home Country | Switzerland |
Issuing Condition | The fund does not charge any issuing commission and/or fees (units are issued at the NAV) |
Redemption Condition | The fund does not charge any redemption commission and/or fees (units are redeemed at the NAV) |
Investment Strategy *** | The objective of the Synchrony Swiss Equity Subfund is long term capital growth by investing in shares of the Swiss companies that make up the SPI® index. Companies are identified and selected based on their fundamentals, using a systematic stock-picking methodology. The Subfund invests at least two-thirds of its assets in shares and other securities or participation rights of companies domiciled or having a predominant amount of their business activity in Switzerland, and which are part of the SPI® index. |
Peculiarities |
Current Price * | 108.00 CHF | 31.03.2025 |
---|---|---|
Previous Price * | 110.02 CHF | 28.03.2025 |
52 Week High * | 112.54 CHF | 03.03.2025 |
52 Week Low * | 99.64 CHF | 16.04.2024 |
NAV * | 108.00 CHF | 31.03.2025 |
Issue Price * | ||
Redemption Price * | ||
Closing Price * | ||
Indicative Minimum Price | ||
Fund Assets *** | 205,586,501 | |
Unit/Share Assets *** | 46,440,955 | |
Trading Information SIX |
YTD Performance | +5.85% |
31.12.2024 - 31.03.2025
31.12.2024 31.03.2025 |
---|---|---|
1 month | -2.86% |
28.02.2025 - 31.03.2025
28.02.2025 31.03.2025 |
3 months | +5.85% |
31.12.2024 - 31.03.2025
31.12.2024 31.03.2025 |
6 months | +0.02% |
30.09.2024 - 31.03.2025
30.09.2024 31.03.2025 |
1 year | +5.63% |
02.04.2024 - 31.03.2025
02.04.2024 31.03.2025 |
2 years | +10.65% |
31.03.2023 - 31.03.2025
31.03.2023 31.03.2025 |
3 years | +17.25% |
16.12.2022 - 31.03.2025
16.12.2022 31.03.2025 |
5 years | - | - |
Equity Participation Rate in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Share of Total Fund Assets in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Real Estate Rate in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
ADDI | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
ADDI Date |
Nestle SA | 10.99% | |
---|---|---|
Novartis AG Registered Shares | 9.84% | |
Roche Holding AG | 9.64% | |
ABB Ltd | 6.40% | |
UBS Group AG | 6.29% | |
Zurich Insurance Group AG | 5.34% | |
Sika AG | 3.64% | |
Lonza Group Ltd | 3.54% | |
Alcon Inc | 3.32% | |
Givaudan SA | 3.30% | |
Last data update | 30.11.2024 |
TER | 0.41% |
---|---|
TER date | 15.09.2024 |
Performance Fee *** | |
PTR | |
Max. Management Fee *** | 0.45% |
Ongoing Charges *** | |
SRRI ***
|
|
SRRI date *** | 28.02.2025 |